In diffuse large B-cell lymphoma (DLBCL), NETs recruited via the IL8-CXCR2 axis activate TLR9, increasing NF-κB and p38 pathways and promoting tumor proliferation and growth [73,74,75]. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.